Arrivent Biopharma, Inc. · NASDAQ:AVBP

Orbimed Advisors LLC reported a 7.50% stake in Arrivent Biopharma, Inc. (Schedule 13D/A)

Event Aug 11, 2025 · Filed Aug 13, 2025

Orbimed Advisors LLC reported a 7.50% stake in Arrivent Biopharma, Inc., 3,027,328 shares, with active intent on Aug 11, 2025. Filed Aug 13, 2025 (Schedule 13D/A).

Stake
7.50%
Shares
3,027,328
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC7.50%3,027,328
OrbiMed Capital GP VIII LLC3.70%1,513,664
OrbiMed Asia GP IV, L.P.3.70%1,513,664
OrbiMed Advisors IV Limited3.70%1,513,664

Source

View original at SEC

Related